Tech Company Financing Transactions

Alnara Pharmaceuticals Funding Round

Alnara Pharmaceuticals, operating out of Cambridge, secured $35 million in investment from MPM Capital, Bessemer Venture Partners and Frazier Healthcare Partners.

Transaction Overview

Company Name
Alnara Pharmaceuticals
Announced On
1/28/2010
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series B
Investors

MPM Capital (Lead Investor) (Ashley Dombkowski)

Bessemer Venture Partners

Frazier Healthcare Partners (James Topper)

Third Rock Ventures

Proceeds Purpose
The money will be needed to complete the application and prepare for the potential commercial introduction of liprotamase, which could hit the U.S. market as early as the fourth quarter of this year.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
840 Memorial Dr.
Cambridge, MA 02139
USA
Phone
(617) 349-3690
Website
www.alnara.com
Email Address
[email protected]
Overview
Alnara Pharmaceuticals Inc is a pharmaceutical company developing innovative non-systemic protein therapeutics for the treatment of metabolic and inflammatory diseases.
Profile
Alnara Pharmaceuticals LinkedIn Company Profile
Social Media
Alnara Pharmaceuticals Company Twitter Account
Company News
Alnara Pharmaceuticals News
Facebook
Alnara Pharmaceuticals on Facebook
YouTube
Alnara Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Alexey Margolin
  Alexey Margolin LinkedIn Profile  Alexey Margolin Twitter Account  Alexey Margolin News  Alexey Margolin on Facebook
Chief Medical Officer
Lee Brettman
  Lee Brettman LinkedIn Profile  Lee Brettman Twitter Account  Lee Brettman News  Lee Brettman on Facebook
Vice President
Thomas Rowland
  Thomas Rowland LinkedIn Profile  Thomas Rowland Twitter Account  Thomas Rowland News  Thomas Rowland on Facebook
Vice President
Hugh Wight
  Hugh Wight LinkedIn Profile  Hugh Wight Twitter Account  Hugh Wight News  Hugh Wight on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/28/2010: The Receivables Exchange venture capital transaction
Next: 1/29/2010: Tora Trading Services venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.